WEE1 and cancer: Furthermore, loss of the G1 checkpoint is frequent in tumors and potentially provides increased reliance on the G2 checkpoint [534], thereby selectively sensitizing cancer cells to checkpoint inhibitors like adavosertib (AZD1775), which is a highly selective inhibitor of WEE1 [535,536,537,538].